Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Francesco Guerrera

Showing results (91-100 of 155) with videos related to

Pageof 16
Sort By:
Frontiers in Surgery|March 21, 2022
Lung Biopsy With a Non-intubated VATS Approach in an Obese Population: Indications and ResultsRoberto Cherchi, Paolo Albino Ferrari, Francesco Guerrera, et al.
Clinical Lung Cancer|September 16, 2018
KRAS-specific Amino Acid Substitutions are Associated With Different Responses to Chemotherapy in Advanced Non-small-cell Lung CancerStéphane Renaud, Francesco Guerrera, Joseph Seitlinger, et al.
Journal of Thoracic Disease|August 14, 2025
Short-term results of salvage surgery after immune and target therapies in non-small cell lung cancerMarco Chiappetta, Carolina Sassorossi, Filippo Lococo, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|October 10, 2024
Improved Event-Free Survival After Complete or Major Pathologic Response in Patients With Resectable NSCLC Treated With Neoadjuvant Chemoimmunotherapy Regardless of Adjuvant Treatment: A Systematic Review and Individual Patient Data Meta-AnalysisDaniele Marinelli, Antonio Nuccio, Alessandro Di Federico, et al.
European Journal of Cancer (Oxford, England : 1990)|December 14, 2020
Kinomic profiling of tumour xenografts derived from patients with non-small cell lung cancer confirms their fidelity and reveals potentially actionable pathwaysFabrizio Tabbò, Francesco Guerrera, Adrienne van den Berg, et al.
Interactive Cardiovascular and Thoracic Surgery|December 21, 2019
Epidemiology and management of primary spontaneous pneumothorax: a systematic reviewPaolo Mendogni, Jacopo Vannucci, Marco Ghisalberti, et al.
Plos One|January 6, 2016
The Influence of Tissue Ischemia Time on RNA Integrity and Patient-Derived Xenografts (PDX) Engraftment Rate in a Non-Small Cell Lung Cancer (NSCLC) BiobankFrancesco Guerrera, Fabrizio Tabbò, Luca Bessone, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|April 17, 2014
Thymic carcinoma: a cohort study of patients from the European society of thoracic surgeons databaseEnrico Ruffini, Frank Detterbeck, Dirk Van Raemdonck, et al.
Diagnostics (Basel, Switzerland)|April 12, 2025
The Role of ctDNA for Diagnosis and Histological Prediction in Early Stage Non-Small-Cell Lung Cancer: A Narrative ReviewCarolina Sassorossi, Jessica Evangelista, Alessio Stefani, et al.
Lung Cancer (Amsterdam, Netherlands)|December 28, 2013
Outcome of surgically resected thymic carcinoma: a multicenter experiencePier Luigi Filosso, Francesco Guerrera, Angelo Erino Rendina, et al.
Pageof 16

Showing results (91-100 of 155) with videos related to

Sort By:
Pageof 16
Frontiers in Surgery|March 21, 2022
Lung Biopsy With a Non-intubated VATS Approach in an Obese Population: Indications and ResultsRoberto Cherchi, Paolo Albino Ferrari, Francesco Guerrera, et al.
Clinical Lung Cancer|September 16, 2018
KRAS-specific Amino Acid Substitutions are Associated With Different Responses to Chemotherapy in Advanced Non-small-cell Lung CancerStéphane Renaud, Francesco Guerrera, Joseph Seitlinger, et al.
Journal of Thoracic Disease|August 14, 2025
Short-term results of salvage surgery after immune and target therapies in non-small cell lung cancerMarco Chiappetta, Carolina Sassorossi, Filippo Lococo, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|October 10, 2024
Improved Event-Free Survival After Complete or Major Pathologic Response in Patients With Resectable NSCLC Treated With Neoadjuvant Chemoimmunotherapy Regardless of Adjuvant Treatment: A Systematic Review and Individual Patient Data Meta-AnalysisDaniele Marinelli, Antonio Nuccio, Alessandro Di Federico, et al.
European Journal of Cancer (Oxford, England : 1990)|December 14, 2020
Kinomic profiling of tumour xenografts derived from patients with non-small cell lung cancer confirms their fidelity and reveals potentially actionable pathwaysFabrizio Tabbò, Francesco Guerrera, Adrienne van den Berg, et al.
Interactive Cardiovascular and Thoracic Surgery|December 21, 2019
Epidemiology and management of primary spontaneous pneumothorax: a systematic reviewPaolo Mendogni, Jacopo Vannucci, Marco Ghisalberti, et al.
Plos One|January 6, 2016
The Influence of Tissue Ischemia Time on RNA Integrity and Patient-Derived Xenografts (PDX) Engraftment Rate in a Non-Small Cell Lung Cancer (NSCLC) BiobankFrancesco Guerrera, Fabrizio Tabbò, Luca Bessone, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|April 17, 2014
Thymic carcinoma: a cohort study of patients from the European society of thoracic surgeons databaseEnrico Ruffini, Frank Detterbeck, Dirk Van Raemdonck, et al.
Diagnostics (Basel, Switzerland)|April 12, 2025
The Role of ctDNA for Diagnosis and Histological Prediction in Early Stage Non-Small-Cell Lung Cancer: A Narrative ReviewCarolina Sassorossi, Jessica Evangelista, Alessio Stefani, et al.
Lung Cancer (Amsterdam, Netherlands)|December 28, 2013
Outcome of surgically resected thymic carcinoma: a multicenter experiencePier Luigi Filosso, Francesco Guerrera, Angelo Erino Rendina, et al.
Pageof 16